Draft Programme (05 May 2016)
|
|
- Nelson Freeman
- 5 years ago
- Views:
Transcription
1 Innovations in sustainable Draft Programme (05 May 2016) Draft 7 th Meeting of the South-East Asia Region Immunization Technical Advisory Group (SEAR ITAG) 6-10 June 2016, New Delhi (India) Day 1, Monday, 6 June :00 17:30 Pre-meeting agenda Review of the progress of implementation of the recommendation of ITAG meeting in 2015 Review of the Expanded Programmes on Immunization in SEAR countries based on the reports submitted by the country NITAGs Update on current status of regional priorities (structured format) Identification of discussion points for the thematic areas covered in 4-day programme, 7-10 June ITAG Members SAGE Chair+2 Members RCCPE Chair NITAG/NCIP chairs/members UNICEF (HQ and ROs) WHO (HQ and SEARO) Day 2, Tuesday, 7 June
2 Opening Session Registration Opening Session, RD s speech, photo etc. WHO Regional Director Introduction of ITAG Members; participants ITAG Chair Tea Break Session 1: Review of progress and achievements since last ITAG Progress on implementation of recommendations from the 6 th Meeting of SEAR ITAG, June :30 12:00 Progress of NITAG Establishment in SEAR Review of country EPI by NITAGs a summary WHO SEARO 12:00 12:15 Update on implementation of Global Vaccine Action WHO HQ Plan 12: Validation of MNTE - Indonesia MoH Indonesia 12:30-13:00 13:00 14:00 Lunch Break Session 2: Implementing Vaccine Action Plan 14:00 14:15 SEAR Vaccine Action Plan Summary of challenges WHO SEARO and way forward 14: Efforts to reach every child - addressing inequities in immunization WHO & UNICEF MoH India & MoH Nepal a. Brief introductory remarks/presentation b. Country experiences (2 countries) 15:00 15:15 15:15 15:45 Tea Break 15:45 16:00 Nepal Immunization Act-2016: Key aspects MoH Nepal 16:00 17:00 Innovations to sustainable immunization financing in the context of country transition Panel discussion Using HSS approach to address country priority areas of immunization: Lessons learned & challenges - Bangladesh - Myanmar ITAG closed discussion 19:00 21:00 Reception MoH Bangladesh MoH Myanmar Day 3, Wednesday, 8 June 2016 Session 3 Hepatitis B Situation and way forward 09:00 10:00 Regional Viral Hepatitis Action Plan (20 WHO-SEARO Regional Hepatitis B Situation and Action Plan - way WHO-SEARO forward (20 2
3 (20 10:00-10:30 Tea Break Session 4 - Polio Eradication and Endgame Strategy Situation Update 10:30 12:15 Regional Update on Polio Eradication and endgame WHO SEARO strategy implementation (20 Global Update (20 WHO HQ IPV and bopv supply situation (15 UNICEF SD Stretching IPV supplies (15 WHO SEARO/HQ Containment of polioviruses as per GAP III an update WHO SEARO (20 (15 12:15-13:15 Lunch Session 5 - Polio Eradication and Endgame Strategy Outbreak response 13:15 15:30 Outbreak response assessment (OBRA) and follow-up actions in Myanmar (20+10 WHO-SEARO & MoH Myanmar Updated national outbreak response plan in DPR Korea MoH DPR Korea (20 Responding to a poliovirus outbreak or event post WHO HQ Polio team switch generic SOPs (20 Specific protocol for response to type 2 poliovirus (30 (10 WHO SEARO/ UNICEF ROSA Preparing a country roadmap for outbreak response postswitch brief orientation (25 All countries 15:30-16:00 Tea-break Session 6 Polio Eradication and Endgame Strategy Transition Planning 16:00 17:15 Post- Polio Eradication Transition Planning Principles and Steps (30 Transition planning progress India (15 Evaluation of SMO network Bangladesh (15 (10 17:15 18:00 Developing action plans for transition of polio assets: Break-out session with 5 countries Bangladesh, India, Indonesia, Myanmar, Nepal ITAG closed discussion WHO HQ WHO India/UNICEF India WHO Bangladesh MoH, WHO, UNICEF 3
4 Day 4, Thursday, 9 June 2016 Session 7: Accelerating Measles Elimination and Rubella/CRS Control 09:00 10:30 Regional Measles and Rubella update situation, WHO SEAR challenges and way forward (30 Global Measles and Rubella update (20 WHO HQ IVB Re-emergence of measles in Bhutan case study (15 MoH Bhutan Managing measles outbreak in Sri Lanka an MoH Sri Lanka experience (15 (10 10:30 11:00 Tea Break 11:00 11:20 Status of MR surveillance in SEAR and recent actions WHO SEAR to improve sensitivity, including molecular epidemiology (20 11:20 11:30 Initiating sentinel CRS surveillance MoH Maldives 11:30 12:30 Group Work: Closing immunity gaps and All countries (4 goups) strengthening surveillance for measles and rubella 12:30 13:30 Lunch Break 13:30 15:00 Presentations from group work (15 mins presentation + 5 mins discussion for each group) 15:00 15:30 Tea Break Session 8: Strengthening data quality for action 15:30 17:15 Data Quality Improving immunization information, recording & reporting in SEAR (20 WHO SEAR Home based records (10 UNICEF Strengthening weekly AFP and measles case based WHO SEAR data reporting (15 Addressing missed opportunities and planning for new MoH Timor Leste CES methodology (15 Follow up to EPI/VPD Surveillance Review - Sri MoH Sri Lanka Lanka (15 Follow up to EPI/Surveillance review Thailand (15 MoH Thailand ( : 15 ITAG closed discussion 4
5 Day 5, Friday 10 June 2016 Session 9 - Maternal and Neonatal Tetanus Elimination in SEAR 09:00 09:30 MNTE maintenance plan for SEAR WHO SEAR Session 10 - Strengthening Vaccine Quality and Management 09:30 10:30 Vaccine availability & supply (15 UNICEF SD New NRA Assessment tool and progress made in NRA WHO SEAR strengthening in SEAR: special reference to Bangladesh and Myanmar (20 Vaccine management & assessment (EVM UNICEF ROSA/EAPRO assessment new tool) 15 mins 10:30 11:00 Tea Break AEFI field investigation & Causality Assessment WHO SEAR 11:00 11:45 guidelines Session 11 - New and Under-Utilized Vaccines introduction in SEAR 11:45 12:15 Dengue Vaccine Development (WHO position paper and SAGE Recommendations) Update : sharing experiences on: - IPV/PCV post introduction evaluation 12:15 13:00 - Rotavirus vaccine Introduction - JE Introduction 13:00-13:15 s 13:15-14:15 Lunch Break 14:15 15:30 ITAG Closed discussion ITAG Recommendations and Closing WHO - HQ MoH Bangladesh MoH India MoH Indonesia 5
SEA-Immun-105 Distribution: General. WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG)
SEA-Immun-105 Distribution: General WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) Report of the Seventh Meeting of SEAR-ITAG New Delhi, India, 7 10 June 2016 World Health
More informationSouth-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) Meeting Report
The eighth meeting of the World Health Organization's South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) was held from 13 to 16 June 2017 in New Delhi, India. SEAR-ITAG is a technical
More informationMonthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
More informationSixth Meeting of the South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG)
The Sixth Meeting of the 's South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) was held during the period from 15 to 19 July 2015 in New. SEAR-ITAG is a regional technical expert
More informationReport of the Seventh Meeting SEAR- ITAG
WHO South East Asia Regional - Immunization Technical Advisory Group (SEAR- ITAG) Report of the Seventh Meeting SEAR- ITAG New, 7 to 10 June 2016 i Table of contents Contents Page Table of contents ii
More informationImmunization and Vaccine Development (IVD) SEARO
VPD Update for Week 33, 2014 Data as of 18 August 2014 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus case by type, SEAR WPV Type
More informationThe Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region
The Journal of Infectious Diseases SUPPLEMENT ARTICLE The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region Sunil Bahl, 1 Andreas Hasman, 2 Abu Obeida Eltayeb, 3 Douglas
More informationProtecting people from Vaccine Preventable Diseases
Protecting people from Vaccine Preventable Diseases Immunization and Vaccine Development South East Asia Region Strategic Plan (2010 2013) Table of Contents INTRODUCTION...2 1. THE IVD MISSION IN THE GLOBAL
More informationExpanded Programme on Immunization (EPI)
Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationTable 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)
EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb
More informationProgress reports on selected Regional Committee resolutions:
REGIONAL COMMITTEE Provisional Agenda item 4.7.2 Sixty-sixth Session SEA/RC66/14 SEARO, New Delhi, India 10 13 September 2013 19 July 2013 Progress reports on selected Regional Committee resolutions: 2012:
More informationWHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES
WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES Immunization and vaccine development in the last decade Since the Millennium Summit in 2000, immunization substantial international
More informationTable 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210
EPI history EPI launched in 980 HepB vaccine introduced in 003 AD syringes introduced in 003 HepB birth dose introduced in 004 DTP-HepB vaccine introduced in 006 MCV introduced in 008 DTP-Hib-HepB vaccine
More informationExpanded Programme on Immunization (EPI)
Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationImmunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: January 03, 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
More information3. CONCLUSIONS AND RECOMMENDATIONS
3. CONCLUSIONS AND RECOMMENDATIONS 3.1 Polio Endgame Strategy Conclusions 1. The TAG welcomes the RCC conclusion that Western Pacific Region maintains its polio-free status, and commends China for the
More informationMonthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
More informationProgrammatic Feasibility of Measles Elimination in South East Asia Region
Programmatic Feasibility of Elimination in South East Asia Region A. Introduction: In 2005, World Health Assembly resolution WHA58.15 endorsed the Global Immunization Vision and Strategies (GIVS) that
More informationMeasles and Rubella Fact Sheet SEAR #
and Fact Sheet SEAR 8-9 Table : South-East Asia Regional (SEAR) Strategic Plan 7- Goal: To reduce the number of measles deaths by 9 in relative to estimates. Objectives: Achieve at least 9 national Containing
More informationREPORT Of the FIRST SOUTH-EAST ASIA REGIONAL TECHNICAL ADVISORY GROUP ON IMMUNIZATION (SEAR ITAG) MEETING July 2008 Bangkok, Thailand
1 REPORT Of the FIRST SOUTH-EAST ASIA REGIONAL TECHNICAL ADVISORY GROUP ON IMMUNIZATION (SEAR ITAG) MEETING 14-15 July 2008 Bangkok, Thailand 2 First South-East Asia Regional Technical Advisory Group on
More informationExpanded Programme on Immunization (EPI)
Bhutan 2017 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles containing
More informationPOLIO ERADICATION AND POST-CERTIFICATION STRATEGY
POLIO ERADICATION AND POST-CERTIFICATION STRATEGY PRE-BOARD MEETING 5 June 2018, Geneva Reach every child www.gavi.org Agenda Topic Presenter 1. Polio eradication update WHO 10 minutes 2. IPV supply, demand
More informationHIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region
HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region Padmini Srikantiah, MD MPH HIV/AIDS Unit WHO- Regional Office for Southeast Asia The HIV epidemic in Southeast Asia Estimated
More informationRegional workshop on surveillance standards for measles, rubella and priority vaccine-preventable diseases
SEA-Immun-108 Distribution: General Regional workshop on surveillance standards for measles, rubella and priority vaccine-preventable diseases Kathmandu, Nepal, 19 23 September 2016 World Health Organization
More informationTotal population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594
Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%
More informationHow to present the European Vaccine Action Plan (EVAP)
How to present the European Vaccine Action Plan 2015-2020 () HOW TO USE THIS DOCUMENT By adopting the European Vaccine Action Plan 2015-2020 () in September 2014, all Member States of the WHO European
More informationTable 1: Basic information 2017
EPI history EPI launched in 978 OPV and MCV introduced in 987 AD syringes introduced in 00 HepB vaccine introduced in 003 MCV introduced partially in 008 and made available nationwide in 0 DTP-Hib-HepB
More informationExpanded Programme on Immunization (EPI)
Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationAgenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 6 8 November 2012 CCV/CICG, Geneva
Version: 2 November 2012 Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 6 8 November 2012 CCV/CICG, Geneva Tuesday, 6 November 2012 Time Session Purpose of session, target
More informationFirst South-East Asia Regional Technical Advisory Group on Immunization (SEAR ITAG) Meeting
SEA-Immun-17 Distribution: Limited First South-East Asia Regional Technical Advisory Group on Immunization (SEAR ITAG) Meeting A Brief Report 14 15 July 2008, Bangkok, Thailand Regional Office for South-East
More informationTotal population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100
Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing
More informationTotal population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093
DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal
More informationAgenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 1 3 April 2014 CCV/CICG, Geneva
Version: 14 March 2014 Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 1 3 April 2014 CCV/CICG, Geneva Tuesday, 1 April 2014 Time Session Purpose of session, target outcomes
More informationUpdate on Polio Eradication in the World Health Organization South-East Asia Region, 2013
SUPPLEMENT ARTICLE Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013 Patrick Michael O Connor, 1 Robert Allison, 1 Arun Thapa, 1 Sunil Bahl, 2 Supamit Chunsuittiwat,
More informationReduction of child and maternal mortality in South-East Asia Region WHO-SEARO. UNESCAP Forum, New Delhi: 17 Feb 2012
Reduction of child and maternal mortality in South-East Asia Region WHO-SEARO 1 1 Progress in MDG 4 in SEAR Country Under 5 Mortality 2010 Target U5MR MDG 4 Status MDG4: Reduction of U5MR by two thirds
More informationREGIONAL COMMITTEE Provisional Agenda item 5.3. SEA/RC64/8 Inf. Doc. Jaipur, Rajasthan, India 6 9 September August 2011
REGIONAL COMMITTEE Provisional Agenda item 5.3 Sixty-fourth Session SEA/RC64/8 Inf. Doc. Jaipur, Rajasthan, India 6 9 September 2011 2 August 2011 The attached document provides detailed and supplementary
More informationMeeting of the Strategic Advisory Group of Experts (SAGE) on Immunization Agenda October 2018 CICG, Geneva, Switzerland Version: 19 October 2018
Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization Agenda 23-25 October 2018 CICG, Geneva, Switzerland Version: 19 October 2018 Tuesday, 23 October 2018 Time Session 09:15 Welcome
More informationSOUTH-EAST ASIA ACTION PLAN
SOUTHEAST ASIA ACTION PLAN 20162020 Cover Photos by: Ist Row: Ministry of Public Health Democratic People s Republic of Korea WHO/Bangladesh/R Kumar WHO/Bhutan WHO/India/R Kumar IInd Row: Ministry of Health/Epidemiology
More informationSEA-Immun-115 Distribution: General. South-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE)
SEA-Immun-115 Distribution: General South-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE) Report of the Ninth Meeting Colombo, Sri Lanka, 7-9 December 2016 World Health Organization
More informationMinisterial Round Table: Accelerating implementation of WHO FCTC in SEAR
REGIONAL COMMITTEE Provisional Agenda item 14.3 Sixty-eighth Session SEA/RC68/28 Dili, Timor-Leste 7 11 September 2015 20 July 2015 Ministerial Round Table: Accelerating implementation of WHO FCTC in SEAR
More informationTable 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.
EPI history EPI launched in 978 with DPT, OPV, BCG and typhoid vaccines TT immunization of pregnant women introduced in 983 MCV introduced in 985 HepB piloted in 00 and made universal in 0 MCV introduced
More informationSouth-East Asia Regional Committee resolution (September 2013, New Delhi)
South-East Asia Regional Committee resolution (September 2013, New Delhi) SEAR Member States adopted the goal of measles elimination and rubella/crs control in the South-East Asia Region by 2020. Achieving
More informationEnding preventable maternal and child mortality
REGIONAL COMMITTEE Provisional Agenda item 9.3 Sixty-ninth Session SEA/RC69/11 Colombo, Sri Lanka 5 9 September 2016 22 July 2016 Ending preventable maternal and child mortality There has been a significant
More informationPolio Eradication in India. Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014
Polio Eradication in India Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014 History of Polio in India Number of Cases 200,000 200,000 OPV Introduced in RI - 1978 150,000
More informationProgress towards achieving Millennium Development Goal 5 in South-East Asia
DOI:.1111/j.1471-528.211.38.x www.bjog.org Commentary Progress towards achieving Millennium Development Goal 5 in South-East Asia M Islam Family Health and Research, World Health Organisation, South East
More informationDraft agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 5-7 April 2011 CCV/CICG, Geneva
Version: 10 February 2011 Draft agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 5-7 April 2011 CCV/CICG, Geneva Tuesday, 5 April 2011 Time Session Purpose of session, target
More informationProgress reports on selected Regional Committee resolutions
REGIONAL COMMITTEE Provisional Agenda item 9 Seventy-first Session SEA/RC71/13 Rev.1 New Delhi, India 3 7 September 2018 21 August 2018 Progress reports on selected Regional Committee resolutions Progress
More informationPolio post-certification strategy
1 Polio post-certification strategy SAGE Meeting, Geneva, 17 April 2018 Michel Zaffran, Director, Polio Eradication, WHO On Behalf o the GPEI Polio Eradication and Endgame Strategy 1. Poliovirus detection
More informationJoint National/International Expanded Programme on Immunization and Vaccine Preventable Disease Surveillance Review
SEA-Immun-97 Distribution: General Joint National/International Expanded Programme on Immunization and Vaccine Preventable Disease Surveillance Review Democratic Socialist Republic of 16 26 October 2015
More informationBeyond effectiveness: research on vaccines seen as a continuum
Beyond effectiveness: research on vaccines seen as a continuum Alejandro Cravioto, MD, PhD Facultad de Medicina, Universidad Nacional Autónoma de México Chair, Strategic Advisory Group of Experts (SAGE)
More informationTotal population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000
India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written
More informationSouth-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE)
SEA-Immun-107 Distribution: General South-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE) Report of the Eighth Meeting Bali, Indonesia, 22 24 September 2015 World Health Organization
More informationGlobal Measles and Rubella Update November 2018
Global Measles and Rubella Update November 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep
More informationGlobal Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide
Global Overview Polio Partners Group, December 2015 1 Note: Gavi requirements of $122.2 million are not included in this slide The Polio Endgame Plan 1. Poliovirus detection & interruption 2. OPV2 withdrawal,
More informationPolio Eradication and Surveillance. December
Polio Eradication and Surveillance December 2017 1 Acute Flaccid Paralysis (AFP) surveillance for polio eradication: >100,000 reported AFP per year December 2017 2 Global Laboratory Network for Polio Eradication
More informationVPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO
VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus cases confirmed by type,
More informationRegional Vaccine Policy for South-East Asia Region
Regional Vaccine Policy for South-East Asia Region Prepared by: WHO Task Force for Development of a Regional Vaccine Policy World Health Organization Regional Office for South-East Asia New Delhi World
More informationPolio eradication. Report of the Sixth Meeting of the South-East Asia Regional Certification Commission (SEA-RCCPE) Kathmandu, November 2013
SEA-Immun-84 Distribution: General Polio eradication Report of the Sixth Meeting of the South-East Asia Regional Certification Commission (SEA-RCCPE) Kathmandu, 25 27 November 2013 World Health Organization
More informationReport of the Immunization Practices Advisory Committee (IPAC) to SAGE. Dr Christopher Morgan, IPAC Chair October 2015
Report of the Immunization Practices Advisory Committee (IPAC) to SAGE Dr Christopher Morgan, IPAC Chair October 2015 IPAC Meeting: 14-15 October, 2015 v Standing reports Programmatic Suitability for Prequalification
More informationSelected vaccine introduction status into routine immunization
Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF
More informationGlobal Measles and Rubella Update October 2018
Global Measles and Rubella Update October 218 Measles Number of Reported Measles Cases by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug
More informationGlobal Measles and Rubella Update. April 2018
Global Measles and Rubella Update April 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct
More informationPolio endgame strategy The challenges for Asia Pacific Region
Polio endgame strategy The challenges for Asia Pacific Region Vaccinology 2013 1 st International Symposium for Asia Pacific Experts Bangkok, Thailand November 11-14 th, 2013 May Book-Montellano, MD >
More informationCollaborative procedure for licensing Prequalified vaccines
Collaborative procedure for licensing Prequalified vaccines DCVMN meeting Shanghai, China March 2015 World Health Organization, EMP/RHT/PQT rodriguezhernandezc@who.int meekd@who.int Strategic priorities
More informationHealth, the SDGs and the role of Universal Health Coverage: next steps in the South-East Asia Region, to reach those being left behind
Health, the SDGs and the role of Universal Health Coverage: next steps in the South-East Asia Region, to reach those being left behind Background paper: why this Regional Consultation, and why now? This
More informationSummary of findings, decisions and recommendations
14 th Meeting of the Global Commission for the Certification of Poliomyelitis Eradication (GCC) Bali, Indonesia, 20-21 September, 2015 Summary of findings, decisions and recommendations 1 Introduction
More informationRemarkable progress, new horizons and renewed commitment. Ending preventable maternal, newborn and child deaths in South-East Asia Region
Remarkable progress, new horizons and renewed commitment Ending preventable maternal, newborn and child deaths in South-East Asia Region i ii Foreword MDGs 4 and 5 inspired unprecedented efforts by countries
More informationINACTIVATED POLIOVIRUS VACCINE
INACTIVATED POLIOVIRUS VACCINE World Polio Day 2017: Renewing commitment to Global Polio Eradication October Word Polio Day Recommended use of fipv As part of the Polio Eradication and Endgame Strategic
More informationQuantitative Immunization and Vaccines Related Research Advisory Committee (QUIVER) Alan R. Hinman, MD, MPH SAGE meeting October 27, 2009
Quantitative Immunization and Vaccines Related Research Advisory Committee (QUIVER) Alan R. Hinman, MD, MPH SAGE meeting October 27, 2009 Outline QUIVER Composition Draft recommendations from QUIVER meeting
More informationObjective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch
Objective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch Polio Partners Group meeting Geneva 8 December 2014 Michel Zaffran Coordinator, WHO/EPI, IMG Co-chair On behalf
More informationPolio and routine immunisation Alan Brooks
Polio and routine immunisation Alan Brooks Geneva, Switzerland, Background 1 History of polio eradication World Health Assembly Resolution 400 Previous eradication targets Polio cases (thousands) 300 200
More informationTB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO
TB in the SEA Region Review Plans and Progress Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO The SEA Region: 25% of the world s people, but >33% of TB patients Eastern M editerranean Region 5%
More informationGOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights
GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION (indicator G2.2) Highlights As of December 2014, 140 Member States had introduced rubella vaccines; coverage, however, varies from 12% to 94% depending on region.
More informationDraft Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 9 11 April 2013 CCV/CICG, Geneva
Version: 04 April 2013 Draft Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 9 11 April 2013 CCV/CICG, Geneva Tuesday, 9 April 2013 Time Session Purpose of session, target
More informationWHO WHO AIDS 2018 JOIN US AT
WHO AIDS 2018 JOIN US AT WHO at AIDS 2018 TEDROS GHEBREYESUS Director-General, WHO ZSUZSANNA JAKAB WHO Regional Director for Europe REN MINGHUI WHO Assistant Director-General for Communicable Diseases
More informationPolio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions
Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions Global Polio Partners Group (PPG) meeting June 26, 2017 Underlying premise: Transition
More informationEighth Meeting of the International Certification Commission for Polio Eradication for the South-East Asia Region
SEA-Polio-45 Distribution: General Eighth Meeting of the International Certification Commission for Polio Eradication for the South-East Asia Region The Report 13-15 September 2006, New Delhi, India Regional
More informationINTERNATIONAL CERTIFICATION COMMISSION FOR POLIO ERADICATION IN THE SOUTH-EAST ASIA REGION PLAN OF ACTION
WORLD HEALTH ORGANIZATION Regional Office for South-East Asia New Delhi SEA/Polio/11 12 February 1998 RESTRICTED INTERNATIONAL CERTIFICATION COMMISSION FOR POLIO ERADICATION IN THE SOUTH-EAST ASIA REGION
More informationOral Cancer: Rationale for inclusion in SEA Regional NCD Strategy
Oral Cancer: Rationale for inclusion in SEA Regional NCD Strategy Expert Consultation 11.-13.6.2013 Bangkok Dr Habib Benzian Founder The Health Bureau Ltd UK Director Fit for School International UK Senior
More information25th Meeting of the Technical Advisory Group on Immunization and Vaccine-Preventable Diseases in the Western Pacific Region
Meeting Report 25th Meeting of the Technical Advisory Group on Immunization and Vaccine-Preventable Diseases in the Western Pacific Region 26 29 July 2016 Manila, Philippines RS/2016/GE/50(PHL) English
More informationFROM VISION TO RESULTS
FROM VISION TO RESULTS Advancing Health for Billions in the South-East Asia Region BHUTAN, MALDIVES ELIMINATE MEASLES AS REGION-WIDE EFFORTS SCALE UP REGION DEVELOPS, IMPLEMENTS NATIONAL ACTION PLANS TO
More informationCurrent situation and capacity in the South-East Asia Region
Current situation and capacity in the South-East Asia Region Theme: Diabetes / Obesity Chandrika N Wijeyaratne Sri Lanka Medical Association TWG on Regional Action Plan on NCD Bangkok June 2013 INDICATORS
More informationGAVI Role in IPV Introductions
GAVI Role in IPV Introductions Melissa Malhame 12 th WHO/UNICEF Consultation with OPV/IPV Manufacturers and National Regulatory Authorities Geneva, Switzerland, 10 GAVI vaccine support Currently supported
More informationInformation for Access
Information for Access WHO Efforts to Enhance Access to Vaccine Supply UNICEF Vaccine Industry Consultation Copenhagen, October 2017 Tania Cernuschi, Vaccine Supply Supply, Technologies, and Financing
More informationAddendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG)
Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG) Background India was certified polio-free along with 10 other countries of WHO South-East Asia Region
More informationReport to the. GAVI Alliance Board November 2013
Report to the GAVI Alliance Board 21-22 November 2013 Subject: Report of: Authored by: Agenda item: Category: Consent Agenda: Opening of Funding Window for Japanese Encephalitis Hind Khatib-Othman, Managing
More informationHIV Situation in South-East Asia. HIV unit Department of Communicable Diseases
HIV Situation in South-East Asia HIV unit Department of Communicable Diseases Outline Magnitude of HIV burden in South-East Asia Progress towards MDGs Regional success stories Issues and concerns Summary
More informationMessage from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization
Message from Dr Samlee Plianbangchang Regional Director, WHO South-East Asia At the Regional Review Meeting on Immunization 19-23 July 2010 WHO/SEARO, New Delhi Regional Review Meeting on Immunization
More informationWORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC MEETING REPORT
RS/2016/GE/50(PHL) English only WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC MEETING REPORT 25th Meeting of the Technical Advisory Group on Immunization and Vaccine- Preventable Diseases
More informationDevelopment of the Polio Eradication and Endgame Strategic plan
Development of the Polio Eradication and Endgame Strategic plan SAGE Meeting 6 November 2012 Overview Process, Consultations, Development Eradication and Endgame Outcomes and Activities Legacy Planning
More informationMeeting Report June 2018 Manila, Philippines
Meeting Report 27TH MEETING OF THE TECHNICAL ADVISORY GROUP ON IMMUNIZATION AND VACCINE-PREVENTABLE DISEASES IN THE WESTERN PACIFIC REGION 19 22 June 2018 Manila, Philippines WORLD HEALTH ORGANIZATION
More informationReport of the Regional Consultation on Measles
Report of the Regional Consultation on Measles SEARO, New Delhi, India, 25 27 August 2009 Regional Office for South-East Asia SEA-Immun-57 Distribution: General Report of the Regional Consultation on
More informationStatus of Outbreak Vulnerable Countries
Status of Outbreak Vulnerable Countries Hamid Jafari, WHO Robert Linkins, CDC Independent Monitoring Board Meeting 7-8 May, 2013 Outline Non-Endemic Vulnerable & At-Risk Countries Recently infected countries
More informationNutrition Profile of the WHO South-East Asia Region
Nutrition Profile of the WHO South-East Asia Region Table of Contents iii Foreword v WHO Vision and Mandate* Department of Nutrition for Health and Development VISION vi MANDATE vii WHO South-East Asia
More informationPreparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV
Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV Frequently Asked Questions February 2015 Table of Contents Rationale for OPV cessation... 2 About
More informationGlobal Report to SAGE. Fulfillment of previous recommendations & progress highlights
Global Report to SAGE Fulfillment of previous recommendations & progress highlights SAGE Meeting, 8-10 November 2012 J.M. Okwo-Bele, WHO Outline 1 2 3 4 Global progress Regional updates- RTAGs recommendations
More informationGlobal burden and costeffective. tobacco control" Dr Douglas Bettcher Director Prevention of Noncommunicable Diseases World Health Organization
Global burden and costeffective interventions for tobacco control" Dr Douglas Bettcher Director Prevention of Noncommunicable Diseases World Health Organization MultisectoralPolicies for Prevention and
More informationParadigm shift: from dependency to country ownership Seth Berkley, MD Chief Executive Officer of the GAVI Alliance
Paradigm shift: from dependency to country ownership Seth Berkley, MD Chief Executive Officer of the GAVI Alliance Sabin 20 th Anniversary Scientific Forum 25 April 2014 The GAVI Alliance: a public-private
More informationAll photographs used on the cover page are from WHO sources.
WHO Library Cataloguing-in-Publication data World Health Organization, Regional Office for South-East Asia. Achieving the health-related Millennium Development Goals in the South-East Asia region: Measuring
More informationRegional Review on Preparedness for the Switch from topv to bopv in the South-East Asia Region
SEA-Immun-101 Distribution: General Regional Review on Preparedness for the Switch from topv to bopv in the South-East Asia Region 24 25 February 2016 New Delhi, India World Health Organization 2016 All
More information